Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D39A | ISIN: US75955K3005 | Ticker-Symbol: 3SW
Stuttgart
22.01.25
08:12 Uhr
0,080 Euro
0,000
0,00 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
REMARK HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
REMARK HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0800,10509:54
GlobeNewswire (Europe)
890 Leser
Artikel bewerten:
(2)

Delisting of Securities of NanoString Technologies, Inc.; Remark Holdings, Inc.; Sunworks, Inc.; Cyanotech Corporation; Sientra, Inc.; Charge Enterprises, Inc. and others from The Nasdaq Stock Market

Finanznachrichten News

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of NanoString Technologies, Inc. NanoString Technologies, Inc.'s securities were suspended on February 14, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Remark Holdings, Inc. Remark Holdings, Inc.'s securities were suspended on February 14, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Sunworks, Inc. Sunworks, Inc.'s securities were suspended on February 15, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Cyanotech Corporation. Cyanotech Corporation's securities were suspended on February 20, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Sientra, Inc. Sientra, Inc.'s securities were suspended on February 22, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A Common Stock, unit, and warrants of Atlantic Coastal Acquisition Corp. Atlantic Coastal Acquisition Corp.'s securities were suspended on February 26, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Charge Enterprises, Inc. Charge Enterprises, Inc.'s securities were suspended on February 29, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock, rights, and units of Sagaliam Acquisition Corp. Sagaliam Acquisition Corp.'s securities were suspended on March 8, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock, units, and warrants of TG Venture Acquisition Corp. TG Venture Acquisition Corp.'s securities were suspended on March 11, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock, units, and warrants of Altitude Acquisition Corp. Altitude Acquisition Corp.'s securities were suspended on March 14, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of YanGuFang International Group Co., Ltd. YanGuFang International Group Co., Ltd.'s securities were suspended on March 26, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of JOANN, Inc. JOANN, Inc.'s securities were suspended on March 28, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.